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Methods 
1.1 DNA methylation preprocessing 
500ng genomic DNA from blood (cord at birth; whole at age 7) was bisulfite-converted 
using the EZ-DNA methylation kit (Zymo Research, Orange, CA, USA). DNAm was quantified 
using the Illumina HumanMethylation450 BeadChip (HM450k; Illumina, USA) with arrays 
scanned using an Illumina iScan (software version 3.3.28). The protocol followed 
manufacturer instructions using the recommended alternative incubation conditions for use 
with Illumina Infinium arrays. Illumina HumanMethylation450 BeadChips (Illumina, San 
Diego, USA) were run following the manufacturer’s protocol with no modifications. Initial 
quality control of data generated was conducted using GenomeStudio (version 2011.1) to 
determine the status of staining, extension, hybridization, target removal, bisulfite 
conversion, specificity, non-polymorphic and negative controls. 
Samples were distributed across slides in a semi-random approach to minimise the potential 
relationship between batch effects and other variables. During the data generation process 
a wide range of batch variables were recorded in a purpose-built laboratory information 
management system (LIMS). The LIMS also reported QC metrics from the standard control 
probes on the 450k BeadChip for each sample back to the laboratory. 
Samples (nbirth = 25; nage 7 = 8) or probes (nbirth = 7873; nage 7 = 4861) that failed quality 
control (>1% probes/samples with background detection p-value >= 0.05) were excluded 
from further analysis. Sex checks were performed using X/Y chromosome methylation. 
Genotype probes on the HM450k were compared between samples from the same 
individual and against SNP-chip data to identify and remove any sample 
mismatches. Samples were quantile normalised using the dasen function within the 
wateRmelon package (version 1.4.0) in R. Normalization performance was evaluated using 
all three testing metrics in wateRmelon (genki assessing SNP-related probes, dmrse 
assessing imprinted probes and seabi, assessing gender differences). Probes known to be 
cross-reactive, polymorphic and SNP probes were removed (n = 72,068). We also removed 
participants with non-caucasian or missing ethnicity (based on self-reports; n = 61). Cell type 
proportions (CD8 T lymphocytes, CD4 T lymphocytes, natural killer cells, B lymphocytes, 
monocytes and granulocytes) for each participant were estimated using the reference-
based approach detailed in Houseman et al. (2012).  
 
Results 
2.1 QQ plot 
 
SM Figure 1. QQ plot used to compare the epigenome-wide distribution of P-values with the 
expected null distribution. The red line shows the fitted slope to the data. The black line 
represents the theoretical slope without any stratification. A lambda estimate of 0.869 
provided no evidence for inflation of test statistic. 
 
2.2 Volume-specific results 
Cg02219949 DNA methylation at birth correlated with that at age 7 (rho = .854, p < 
.001; SM Figure 2). 
 
SM Figure 2. Correlation of cg02219949 DNA methylation at birth and at age 7. 
 
 Higher methylation of cg02219949 was negatively associated with total hippocampal 
volume ratio across both time points after controlling for intracranial volume (t = -4.37, p = 
1.92*10-5, SM Figure 3A), with little effect on total amygdala volume (t = 0.75, p = 0.45, SM 
Figure 3B). 
 
SM Figure 3. Correlation of cg02219949 DNA methylation at birth with total A) hippocampal 
and B) amygdala volume. 
2.3 Regional analysis 
 We also investigated regional results, including all CpGs within the gene SP6 (n=24). 
Six CpGs shows nominal effects and three of these passed Bonferroni correction for 24 test 
(SM Table 1 and SM Figure 4). 
 
CpG probe methylation change P-value 
cg02219949* 1.36 1.13E-08 
cg03029292* -0.27 1.44E-04 
cg23391107* 0.29 1.23E-03 
cg00598429 -0.12 3.64E-02 
cg17842670 -0.15 3.73E-02 
cg16779251 -0.17 4.47E-02 
cg15951870 0.16 6.57E-02 
cg03668475 -0.05 8.92E-02 
cg17733447 0.12 1.12E-01 
cg06138226 -0.09 1.33E-01 
cg13230424 0.18 1.53E-01 
cg10531725 0.15 1.56E-01 
cg13457515 0.06 3.57E-01 
cg26888147 -0.05 5.05E-01 
cg05044743 0.02 5.20E-01 
cg03071876 0.05 5.83E-01 
cg20020844 0.06 6.05E-01 
cg09439817 -0.01 6.68E-01 
cg09965384 0.01 7.42E-01 
cg27210136 -0.03 7.45E-01 
cg08974244 -0.01 8.41E-01 
cg04663203 0.00 9.17E-01 
cg23355492 0.01 9.37E-01 
cg20556951 0.01 9.38E-01 
SM Table 1. Regional results, including all 24 probes annotated to SP6. Bold indicates 
nominally significant results; * indicate significant results after Bonferroni-correction for 24 
test. Methylation change represents effect of unstandardized methylation residuals, 
corrected for chip and batch effects, on AH volume ratio. 
  SM Figure 4. Graphical representation of regional results. From top to bottom: 
Location of analysed region on chromosome 17; Manhattan plot of all 24 probes annotated 
to SP6 with –log(p-value) plotted on the y-axis. Two significance thresholds (i.e. the orange 
and yellow dotted lines) were added for reference; SP6 gene structure with one intron (line) 
and one exon (wide box), please note two alternative transcription start sites (thin box); 
genomic location of all 24 CpGs and correlation plot. 
 
2.4 Mediation analysis 
 SM Figure 5. Prospective inter-relationship between prenatal life events, SP6cg02219949 DNA 
methylation and AH volume ratio. Solid arrowed lines = significant paths; dashed arrowed 
lines = insignificant paths; * = significant standardized path coefficients; AH ratio = 
amygdala-hippocampus volume ration; ICV = intracranial volume. 
 
2.5 Replication in a schizophrenia study sample 
Sample description 
Cryo-conserved blood samples from participants of the Mind Clinical Imaging 
Consortium (MCIC) study of schizophrenia from four participating sites (the University of 
New Mexico (UNM), the University of Minnesota (UM), Massachusetts General Hospital 
(MGH), and the University of Iowa (UI)) were used to determine DNA methylation. Patients 
had a Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnosis of 
schizophrenia, schizophreniform disorder (n=4) or schizoaffective disorder (n=3), 
established using a Structured Clinical Interview for DSM disorders (SCID; (First, Spitzer, 
Gibbon, & Williams, 2002)) and a review of case files by trained clinicians. In the initial 
cohort, controls were matched to the patient group for age, gender, and parental 
education. Healthy controls were excluded if they had a history of a medical or Axis I 
psychiatric diagnosis. All subjects gave written informed consent prior to study enrolment. 
The human subjects research committees at each of the four sites approved the study 
protocol. For additional details about the participants and clinical measures, see Ehrlich et 
al. (2010). 
 
DNA methylation preprocessing 
Blood samples were obtained from 234 participants and sent to the Harvard Partners 
Center for Genetics and Genomics for DNA extraction. All DNA extraction, bisulphite 
modification and hybridization steps were done blinded to group assignment, the latter two 
were performed at the Mind Research Network Neurogenetics Core Lab on an Infinium 
HumanMethylation27 BeadChip using Illumina Infinium Methylation Assay. Built-in controls 
were used to evaluate the quality of individual arrays. CpG sites with a bead count of less 
than three in five percent of samples or with a detection p-value > 0.05 in at least five 
percent of samples (n = 70) were removed as well as samples having a detection p-value > 
0.05 in at least one percent of CpG sites (n = 0). Subsequently, we performed a quantile 
color bias adjustment of the red and green fluorescence channel intensities. After removing 
one intensity outlier, intensities were normalized using watermelon (Pidsley et al., 2013). 
Next, we removed five samples displaying gender mismatch and corrected our data 
statistically for the effects of chip and bisulphite conversion efficiency. After basic quality 
control procedures, probe intensities were normalized using nanet (instead of danet, 
because the Infinium HumanMethylation27 BeadChip does only have type I beads). Nanet 
quantile normalizes methylated and unmethylated intensities together, and then calculates 
betas. This should equalize dye bias. We also corrected our data statistically for the effects 
of chip and bisulphite conversion efficiency by first estimating coefficients in a linear 
regression model including bisulphite conversion efficiency, chip ID, gender, age and 
diagnostic group as independent variables, and then computing corrected beta values 
regressing out bisulphite conversion efficiency and chip effects only. As a result of this, some 
residualized beta values were outside a range of 0 to 1. We corrected for this by first adding 
the lowest value as a constant to all data points, and then dividing by the largest value to 
ensure methylation values within the range of 0 to 1. The subsequent methylation data set 
comprised 228 subjects (110 schizophrenia patients and 118 healthy controls) and 27,480 
CpG sites. Two CpGs within the SP6 gene - cg23355492 and cg27210136 - were available for 
analysis. 
 
Brain MRI acquisition and preprocessing 
 The T1-weighted structural brain scans at each of the four sites were acquired with a 
coronal gradient echo sequence: repetition time (TR)=2530 ms for 3T, 12 ms for 1.5T; echo 
time (TE)=3.79 ms for 3T, 4.76 ms for 1.5T; inversion time (TI)=1100 for 3T; bandwidth=181 
for 3T, 110 for 1.5T; 0.625×0.625 voxel size ; slice thickness 1.5 mm; 256×256×128 cm 
matrix; field of view (FOV) = 16 cm; number of excitations (NEX) = 1 for 3T, 3 for 1.5T. 
Data from three consecutive volumes were registered, motion corrected, averaged 
and analyzed in an automated manner with atlas-based FreeSurfer software suite 
(http://surfer.nmr.mgh.harvard.edu, Version 4.0.1). This process included volumetric 
segmentation (Desikan et al., 2006; B Fischl & Dale, 2000; B Fischl, Sereno, & Dale, 1999; 
Bruce Fischl et al., 2002) and the estimation of total intracranial volume (ICV) (Buckner et 
al., 2004). Segmentation reconstruction quality were assured by manual inspection of all 
raw MRI volumes and segmented volumes in three planes. The final sample with complete 
structural MRI and DNA methylation data comprised 212 subjects (101 schizophrenia 
patients and 111 healthy controls). 
 
Replication analysis 
 Replication results indicated that AH volume ratio was larger in patients with 
schizophrenia (SM Figure 6A) and differentially related to cg27210136 DNA methylation – 
linked to the gene SP6 - in patients compared to controls (SM Figure 6B). 
 SM Figure 6. Replication of findings in a cross-sectional sample of patients with 
schizophrenia and controls. 
 
2.6 SP6 expression in human hippocampal and amygdala tissue 
 To investigate whether SP6 is expressed in human hippocampal and amygdala tissue, 
we used publicly available data based on six human brains from the Allen Human Brain Atlas 
(http://www.brain-map.org and (Hawrylycz et al., 2012)). In detail, we extracted z-scored 
expression values for two SP6 probes (CUST_487_PI416573500 and 
CUST_497_PI416379584) for six hippocampal (dentate gyrus, CA1/CA2/CA3/CA4 fields and 
subiculum) and six amygdala (amygdalo-hippocampal transition zone, basolateral nucleus, 
basomedial nucleus, central nucleus, cortico-medial group, lateral nucleus) regions. Z-scores 
larger than zero (in red) represent higher expression values relative to other brain regions. 
SM Figure 5 is an exemplary representation of SP6 expression values in the hippocampus 
and the amygdala for one of the two SP6 probes and for one subject. 
 SM Figure 7: SP6 expression values in the human hippocampus and the amygdala based on 
data from the Allen Human Brain Atlas. 
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